Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Aug 21;21(1):855.
doi: 10.1186/s12879-021-06536-3.

Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients

Affiliations
Meta-Analysis

Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients

Zelalem G Dessie et al. BMC Infect Dis. .

Abstract

Background: Mortality rates of coronavirus disease-2019 (COVID-19) continue to rise across the world. The impact of several risk factors on coronavirus mortality has been previously reported in several meta-analyses limited by small sample sizes. In this systematic review, we aimed to summarize available findings on the association between comorbidities, complications, smoking status, obesity, gender, age and D-dimer, and risk of mortality from COVID-19 using a large dataset from a number of studies.

Method: Electronic databases including Google Scholar, Cochrane Library, Web of Sciences (WOS), EMBASE, Medline/PubMed, COVID-19 Research Database, and Scopus, were systematically searched till 31 August 2020. We included all human studies regardless of language, publication date or region. Forty-two studies with a total of 423,117 patients met the inclusion criteria. To pool the estimate, a mixed-effect model was used. Moreover, publication bias and sensitivity analysis were evaluated.

Results: The findings of the included studies were consistent in stating the contribution of comorbidities, gender, age, smoking status, obesity, acute kidney injury, and D-dimer as a risk factor to increase the requirement for advanced medical care. The analysis results showed that the pooled prevalence of mortality among hospitalized patients with COVID-19 was 17.62% (95% CI 14.26-21.57%, 42 studies and 423,117 patients). Older age has shown increased risk of mortality due to coronavirus and the pooled odds ratio (pOR) and hazard ratio (pHR) were 2.61 (95% CI 1.75-3.47) and 1.31 (95% CI 1.11-1.51), respectively. A significant association were found between COVID-19 mortality and male (pOR = 1.45; 95% CI 1.41-1.51; pHR = 1.24; 95% CI 1.07-1.41), and current smoker (pOR = 1.42; 95% CI 1.01-1.83). Furthermore, risk of mortality among hospitalized COVID-19 patients is highly influenced by patients with Chronic Obstructive Pulmonary Disease (COPD), Cardiovascular Disease (CVD), diabetes, hypertension, obese, cancer, acute kidney injury and increase D-dimer.

Conclusion: Chronic comorbidities, complications, and demographic variables including acute kidney injury, COPD, diabetes, hypertension, CVD, cancer, increased D-dimer, male gender, older age, current smoker, and obesity are clinical risk factors for a fatal outcome associated with coronavirus. The findings could be used for disease's future research, control and prevention.

Keywords: Comorbidities; Demographic characteristics; Funnel plot; Heterogeneity; Publication bias; Sensitivity analysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Flow chart of the study search and screening process
Fig. 2
Fig. 2
Forest plot showing the proportion of COVID-19 mortality
Fig. 3
Fig. 3
Forest plot showing the estimate for the effects of age on COVID-19 mortality
Fig. 4
Fig. 4
Forest plot showing the estimate for the effects of gender on COVID-19 mortality
Fig. 5
Fig. 5
Forest plot showing the estimate for the effects of smoking status and obesity on COVID-19 mortality
Fig. 6
Fig. 6
Forest plot showing the estimate for the effects of CVDs and diabetes on COVID-19 mortality
Fig. 7
Fig. 7
Forest plot showing the estimate for the effects of hypertension and COPD on COVID-19 mortality
Fig. 8
Fig. 8
Forest plot showing the estimate for the effects of cancer and cardiac injury on COVID-19 mortality
Fig. 9
Fig. 9
Forest plot showing the estimate for the effects of acute kidney injury, and D-dimer on COVID-19 mortality
Fig. 10
Fig. 10
Funnel plot for publication bias of effect of comorbidities, age, smoking status, obesity, acute kidney injury, gender, and D-dimer on fatal outcome of COVID-19

Similar articles

Cited by

References

    1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R. A novel coronavirus from patients with pneumonia in China, 2019.N. Engl. J. Med. 2020:382:727–733. - PMC - PubMed
    1. Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, Baghbanzadeh M, Aghamohammadi N, Zhang W, Haque U. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol. 2020;49:717–726. doi: 10.1093/ije/dyaa033. - DOI - PMC - PubMed
    1. Organization WH. Coronavirus disease (COVID-2019) situation reports. Geneva: World Health Organization; 2020. https://www.WHOInt/docs/default-source/coronaviruse/situationreports/202.... Accessed 15 Jan 2021.
    1. ECDC. COVID-19 situation update worldwide, as of week 2 2021updated January 2021. https://covid19-country-overviews.ecdc.europa.eu/.
    1. Abate S, Checkol Y, Mantedafro B, Basu B, Ethiopia D. Prevalence and risk factors of mortality among hospitalized patients with COVID-19: a systematic review and Meta-analysis. Bull World Health Organ. 2020 doi: 10.2471/BLT.20.260737. - DOI